canSERV invites applications for "Revolutionising Cancer Patient Care"
- Photo Info
- Download
- 2 additional media items
One document
A further step towards improved cancer research and treatment:
canSERV launches 3rd Challenge-driven Call and invites applications for “Revolutionising Cancer Patient Care”
To improve cancer treatment outcomes and advance the care of cancer patients, the canSERV consortium invites cancer researchers world-wide to apply for free access to cutting-edge transnational research services and training.
As part of the EU Cancer Mission, canSERV strives to accelerate oncology research to foster precision medicine for the benefit of patients across Europe. To this end, a budget of 600.000€ has been allocated for a new Challenge-driven Call for Service Provision - “Revolutionising Cancer Patient Care: Innovative Approaches to Research and Clinical Trials for Improved Treatment Outcomes”.
Projects submitted in response to this call should focus on either:
- Tailoring research to address the different age groups, paediatric patients and elderly patients to ensure optimal treatment outcomes across diverse populations.
- Designing and developing improved clinical trials to address diverse populations and expand the scope to incorporate broader representation of patients from the EU, including efforts to match control groups, thus advancing trial efficiency and equity in treatment access.
CanSERV, a consortium of 18 leading research organisations, offers more than 400 innovative cancer research services. For this Challenge-driven Call, a minimum of two services from the canSERV Service Catalogue should be requested. Training is considered as separate additional services. Please note that canSERV does not fund clinical trials themselves; instead, users can apply for expert advice and support for planning and designing complex clinical trials. The services will be provided by 13 European life science research infrastructures and associated service providers in the following fields:
- Disease models
- Advanced technologies for personalised oncology
- Biomarkers research, development and validation
- New therapeutic solutions
- Accelerated translation into personalised oncology clinical practice
- Open digital research services
- Access to human samples and data
- Clinical trials and design
- Ethical, legal and socio-economic dimensions
- Training
A detailed service list is available in the canSERV Service Catalogue.
Researchers based in European and non-European countries, including junior and senior individual researchers, academic institutes, biotech/pharmaceutical SMEs, groups of scientists, networks and consortia from public and private entities can apply for the call.
Call information:
The overall budget for this first call is 0.6 Mio. EURO.
Launch of the call is today, Tuesday, 28 May 2024.
Submission closes on 28 August, 14.00 CEST.
Applications will be reviewed by an international, independent, expert review panel.
Further information:
canSERV website: www.canserv.eu
Twitter: @canSERV_EU
LinkedIn: canSERV
Project coordination, BBMRI-ERIC:
Prof. Jens K. Habermann, Director General
Judit Balogh, Senior project manager
This project has received funding from the European Union’s Horizon Europe research and innovation programme under grant agreement number 101058620.
The information and views set out in this press release are those of the author(s) and do not necessarily reflect the official opinion of the European Union. Neither the European Union institutions and bodies nor any person acting on their behalf may be held responsible for the use which may be made of the information contained therein.
ARTTIC Innovation GmbH has been advising research and innovation projects for more than 33 years. As project management and communication partner, we make sure that our projects run successfully and that project results and events are disseminated in the best possible way. ARTTIC is a subsidiary of the PNO Group, one of the largest consultancies for publicly funded projects in research and development. For more information, please visit www.arttic-innovation.de.
We take your privacy seriously. Click here to read our privacy policy. If you no longer wish to receive emails from us, please click below.
